Array
(
[1596807573] => Array
(
[wp_privacy_delete_old_export_files] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1596807874] => Array
(
[wp_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596808000] => Array
(
[wordfence_hourly_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1596808081] => Array
(
[wpm_update_stats] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1596810553] => Array
(
[wp_version_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1596813473] => Array
(
[wp_session_garbage_collection] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1596816424] => Array
(
[akismet_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596819411] => Array
(
[yoast_tracking] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596850326] => Array
(
[wp_update_themes] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_update_plugins] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1596867885] => Array
(
[recovery_mode_clean_expired_keys] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596870512] => Array
(
[ai1wm_storage_cleanup] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596876571] => Array
(
[wp_scheduled_auto_draft_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596881711] => Array
(
[delete_expired_transients] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596881752] => Array
(
[wpseo-reindex-links] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596883600] => Array
(
[wordfence_daily_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596981000] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[66ba68d2add5c4cdada519ad9b8d74a5] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1596981000
)
)
)
)
[1597068000] => Array
(
[wordfence_email_activity_report] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1597213490] => Array
(
[wp_site_health_scheduled_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => weekly
[args] => Array
(
)
[interval] => 604800
)
)
)
[1597240200] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[df4ffa396e2271a65f97ac47f8578821] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1597240200
)
)
)
)
[1601157627] => Array
(
[publish_future_post] => Array
(
[aa3f9c41dd8e97586795881a0c603b8d] => Array
(
[schedule] =>
[args] => Array
(
[0] => 472787
)
)
)
)
)
Tal y como viene recogido en la edición de este martes, 3 de marzo, del Boletín Oficial del Estado (BOE), el Instituto de Salud Carlos III ha lanzado la Acción Estratégica en Salud de este año 2015, que es “la principal herramienta de financiación de la I+D+i en el ámbito de la investigación traslacional biomédica”.
Etiquetas: 3 de marzo de 2015, 3/3/2015, acción, Acción Estratégica en Salud, Año 2015, Biomédica, BOE, Boletín Oficial del Estado, Estratégica, Gobierno, I+D+I, Instituto de Salud Carlos III, Investigación, Investigación traslacional biomédica, Madrid, Ministerio de Economía, salud, Sanidad, Traslacional.
Etiquetas: 2012, Aurora Navajas Gutiérrez, Clínica, Desarrollo de medicamentos pediátricos, Ensayos clínicos, Era genómica, Farmacocinética, Farmacodinàmica, Francisco J. de Abajo Iglesias, Industria farmacéutica, Instituto Roche, Investigación, Investigación PCT, Investigación pediátrica, Investigación pediátrica clínica y traslacional, Investigadores clínicos, Jaime del Barrio, Madrid, Medicamentos en Pediatría, Mónica Saldaña Valderas, Necesidad de la investigación pediátrica con medicamentos, Peculiaridades del niño y los fármacos, Pediátrica, Perspectiva de una agencia reguladora, salud, Sanidad, Traslacional.
.gif)